Indorama Ventures’ core ebitda rose 34 per cent year on year. Core net profit increased 68 per cent. Operating profit grew by 46 per cent. Indorama Ventures is a chemical producer. With additional tailwinds from strong volumes and industry supply tightness, due to financial problems being faced by certain competitors in Europe and America, the company has further grown its top line and margins.
The third quarter concluded a great first nine months for Indorama Ventures. It delivered record earnings, beating expectations in all key financials metrics. This strong performance demonstrates the resilience of its business portfolio, and the benefits of its uniquely diversified and integrated business model, which are clearly bearing fruit with increasing momentum.
The company expects the positive momentum to continue in the fourth quarter due to the better margin environment, higher return HVA products, continued volume growth and the realization of full benefits from its strategic actions. The goal is to double ebitda every five years.
In September 2017, the company debuted in Dow Jones Sustainability Index and was ranked among the top five chemical companies globally. Meaningful developments in the PTA and PET businesses, the announced capital expenditure programs and the newly acquired businesses will all play a meaningful role in enhancing earnings growth in 2018 and beyond.
